Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Cash & Equivalents (2020 - 2025)

Historic Cash & Equivalents for Incannex Healthcare (IXHL) over the last 4 years, with Q3 2025 value amounting to $73.3 million.

  • Incannex Healthcare's Cash & Equivalents rose 192095.4% to $73.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $73.3 million, marking a year-over-year increase of 192095.4%. This contributed to the annual value of $15.0 million for FY2025, which is 15489.83% up from last year.
  • Per Incannex Healthcare's latest filing, its Cash & Equivalents stood at $73.3 million for Q3 2025, which was up 192095.4% from $15.0 million recorded in Q2 2025.
  • Incannex Healthcare's Cash & Equivalents' 5-year high stood at $73.3 million during Q3 2025, with a 5-year trough of $2.1 million in Q4 2024.
  • Its 3-year average for Cash & Equivalents is $16.3 million, with a median of $8.0 million in 2024.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first plummeted by 8558.47% in 2024, then surged by 192095.4% in 2025.
  • Quarter analysis of 3 years shows Incannex Healthcare's Cash & Equivalents stood at $14.6 million in 2023, then crashed by 85.58% to $2.1 million in 2024, then skyrocketed by 3393.8% to $73.3 million in 2025.
  • Its Cash & Equivalents was $73.3 million in Q3 2025, compared to $15.0 million in Q2 2025 and $6.7 million in Q1 2025.